A detailed history of Lazari Capital Management, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Lazari Capital Management, Inc. holds 1,928 shares of NVO stock, worth $197,870. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,928
Previous 1,692 13.95%
Holding current value
$197,870
Previous $242 Million 4.95%
% of portfolio
0.1%
Previous 0.11%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$119.07 - $145.42 $28,100 - $34,319
236 Added 13.95%
1,928 $230 Million
Q2 2024

Sep 09, 2024

BUY
$122.71 - $146.91 $207,625 - $248,571
1,692 New
1,692 $242 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Lazari Capital Management, Inc. Portfolio

Follow Lazari Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazari Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lazari Capital Management, Inc. with notifications on news.